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1. Introduction 
Cell adhesion to the extracellular matrix (ECM) is primarily mediated through integrin 
receptors and contributes to numerous physiological and pathological processes. It would 
be most attractive for biomedical implants to interact with the surrounding host tissue in a 
manner which promotes the healing process, beginning with cell adhesion and growth. This 
calls for a good understanding of the mechanisms by which the ECM is involved in the 
control and organization of cellular processes for wound healing and tissue regeneration. 
Alongside the critically important fields of cell signalling, circulating hormones, cytokines 
and extracellular proteases, the role of the structure, organization and stiffness of the ECM 
can be overlooked. It is the intention of this review to discuss the various approaches that 
have been used to mimic the structural and dynamic aspects of native ECM proteins, and 
how these may modulate cell behaviour. It is clear that molecular biology has much to 
contribute, since protein constructs are now routinely expressed, circumventing the need to 
purify protein molecules (e.g. collagen, laminin, vitronectin and fibronectin) from plasma or 
tissue. Thus, protein engineering has become an essential tool for development of multi-
functional mimics of the ECM. Since integrins mediate the signalling pathways involved in 
cell-ECM attachment, and subsequent self-renewal/differentiation in the case of embryonic 
stem cells, these cell surface receptors will be briefly introduced. The review will then move 
onto the key protein components of the ECM and contemporary studies which have utilised 
this knowledge to generate novel biomaterials able to control cell behaviour. 
2. Integrin receptors 
Integrin receptors are recognized as one of the most important cell surface adhesion and 
signalling receptors , and are widely expressed in many cell types such as smooth muscle, 
endothelium, platelets, and osteoclasts. Integrins are a family of heterodimers consisting of 
two transmembrane subunit proteins (ǂ and ǃ) that are non-covalently bound but inter-
dependent for correct ligand binding. Eighteen ǂ and eight ǃ subunits have been listed in 
humans to date with 24 dimeric combinations identified, each having distinct binding 
profiles to the various extracellular ligands. For instance, osteoclasts bind collagen via ǂ1ǃ1 
and ǂ2ǃ1 integrins whereas fibroblasts bind fibronectin (FN) and vitronectin via ǂ5ǃ1 and 
ǂvǃ3 integrins, respectively. Several integrins can recognize the same ligands with varying 
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affinity. Both ǂ and ǃ subunits have large extracellular domains composed of a membrane 
distal, globular head (~ 700-1100 residues). The crystal structures of the extracellular 
segment of ǂvǃ3 in ligand-occupied and non-occupied states have been exceptionally 
important in understanding the ligand/receptor recognition process at the atomic level. 
Electron micrographs of the complete ectodomain, which includes the headpiece with the 
‘lower leg’ calf and epidermal growth factor (EGF)-like domains of the ǂ and ǃ subunits, 
respectively, have been acquired for integrin ǂIIbǃ3 in its rested and activated state. It 
appears that the integrin receptors are in a compact ‘bent’ form when inactive, which results 
in the head domains (the ǃ-propeller and the ǃ-I domain of the ǂ and ǃ subunits, 
respectively) lying close to the cell membrane, and an extended ‘standing’ conformation 
when activated. A low resolution electron micrograph structure of a recombinant 
fibronectin fragment bound to the ‘headpiece’ (the head domains with the thigh and 
hybrid/plexin-semaphorin-integrin (PSI) domains of the ǂ and ǃ subunits, respectively) of 
integrin ǂ5ǃ1 has also been published. The dimensions of the integrin ectodomain in the 
crystal structure are approximately 80 × 90 × 110 Å and a similar estimation can be inferred 
from the accompanying low resolution electron microscopy (EM) structures. Superposing 
the crystal structure onto the electron micrographs has also been informative to 
understanding the large conformational changes associated with the ǂ/ǃ subunits upon 
ligand binding and activation. Both the ǂ and ǃ subunits span the cell membrane and 
interact with the actin cytoskeleton via vinculin or talin during cell signalling.  
The binding of a ligand to an integrin receptor causes tyrosine phosphorylation of the ǃ 
subunit cytosolic domain by v-src. This in turn facilitates the binding of cell actin filaments 
and intermediary proteins (vinculin and talin) which form complexes associated with the 
focal adhesion structures. Thus, integrins are thought to exist on the cell surface in an 
inactive form and can be activated either by binding ECM (outside-in signalling), but also by 
intracellular signalling (inside-out signalling). Outside-in signalling involves cell adhesion, 
proliferation, migration, differentiation and apoptosis. Inside-out signalling involves, for 
example, platelet aggregate via ǂIIbǃ3 activation leading to haemostasis. Integrin receptors 
may alternate between active and inactive states by conformational changes of the ligand 
binding sites from a high affinity state (active) to a low affinity state (inactive). 
Integrin receptors are usually present at 10-100 fold higher concentrations on the cell surface 
than other non adhesive receptors. Moreover, it has been noted that integrins cluster when 
binding to their ligands , which can be observed at focal adhesions by immuno-microscopy. 
It is likely that the ECM binds a large number of integrins in a polyvalent manner, 
increasing binding affinity. However, tight regulation over integrin recruitment activation 
state and binding affinity must be maintained in order to facilitate transitional cell 
detachment during cell migration. In association with the formation of focal adhesions is a 
force dependent “adhesion strengthening” process. This adhesion reinforcement can be 
induced through the use of synthetic ligand matrices as discussed further below. 
3. Key protein components of the ECM 
3.1 Vitronectin 
Vitronectin is a small multifunctional adhesive glycoprotein which is mostly present in the 
blood as a monomer, but can also be found as a multimer (up to 16-mer) in the ECM of 
various tissues. The polypeptide chains often can be in the form of two molecular species of 
around 60 and 75 kDa, of which up to 30% is a result of glycosylation.  The recognized cell 
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binding domain sequence ‘arginine-glycine-aspartic acid’ (‘RGD’) is present, facilitating 
binding to the integrin subtypes ǂvǃ3 and ǂvǃ5 and through this, cell adhesion is initiated. 
The formation of multimeric vitronectin clusters has been shown to increase heparin 
binding when compared to the monomeric form. These multimers can also form following 
binding of the molecule to plasminogen activity inhibitor PAI-1. More recently, it has been 
shown that to achieve enhancement of cell adhesion and spreading, oligomerisation must be 
initiated and that this process requires the heparin binding domain. A newly engineered 
construct called sVnHBD represents the minimal vitronectin domain requirement for 
integrin dependent cell adhesion and spreading function of vitronectin (Fig. 1). Senile 
plaques in the Alzheimer-diseased brain have been shown to have vitronectin 
immunoreactivity. Further study suggested that vitronectin aggregation mirrors that of 
amyloid protein, the misfolded products of which may therefore contribute to age-related 
amyloid disease.  
 
 
Fig. 1. (a) Recombinant vitronectin constructs: Vn, sVn, and sVnHBD constructs were 
generated by cloning respective vitronectin inserts into pRSETa for poly-histidine tag fusion 
or pGEX6P2 vector for GST fusion. (b) Purified vitronectin proteins were subjected to 12% 
reducing SDS-PAGE to assess the level of purity. Lane 1 is GST-Vn, lane 2 is GST-sVn and 
lane 3 is GST-sVnHBD. M represents the marker lane showing the marker weight in KDa. 
(Reprinted from FEBS Lett., vol. 584, C. R. Chillakuri, C. Jones and H. J. Mardon, Heparin 
binding domain in vitronectin is required for oligomerization and thus enhances integrin 
mediated cell adhesion and spreading, 3287-91, Copyright 2010, with permission from 
Elsevier.). 
3.2 Collagen 
Collagen is a multichain glycoprotein constructed from three polypeptide units forming a 
unique triple-helix conformation. It is a major structural component if the ECM and the 
most abundant of the structural proteins.  There are at least 20 different kinds of genetically 
distinct molecules which based on structural features can be categorized as fibril forming 
(types I, II, III, V and XI) and network-forming (types IV, VIII and X), with type I being the 
most common in the ECM. This key component of the ECM is a versatile substrate for 
supporting cell proliferation and differentiation. Collagen in itself represents a very large, 
active field of research, the scope of which cannot be given justice in this review; the reader 
is therefore directed to previous, excellent reviews such as that by. Structural and functional 
collagen mimetic peptides (CMPs) harboring integrin binding motifs (GFOGER) to achieve 
www.intechopen.com
 On Biomimetics 
 
510 
‘bioadhesiveness’ have proven useful in the synthesis of biologically relevant matrices when 
used in combination with polymeric scaffolds, for the culture of hepatic cells towards liver 
tissue engineering. A recent innovation has been to embed collagen microfibres with 
defined orientations and densities in engineered elastin-like matrices, yielding thin lamellae 
with a specified stiffness, which have been tested in vivo in tissue engineering.  
3.3 Laminin 
Interactions via the basement membrane are mediated by the engagement of laminin with 
several integrins including ǂ3ǃ1 ǂ6ǃ1 ǂ7ǃ1 ǂ6ǃ4. The structural conformation of laminin 
involves three non-identical polypeptide chains: ǂ, ǃ and Ǆ, which form cross shaped 
molecules in mammals. There are five ǂ, three ǃ and three Ǆ subunits identified which can 
combine to produce 15 isoforms. The function of laminin is determined by the subunit 
combination which can be selective for multiple cell adhesive regions including the RGD 
motif, which is located on the amino-terminal half of the ǂ chain. It has been determined 
that integrin binding is specifically governed by the ǂ chains. The mouse laminin ǂ1 chain 
2719-2730 (RKRLQVQLSIRT, termed AG73) is a syndecan-binding peptide which promotes 
cell adhesion, migration and invasion. In an elegant study demonstrating the importance of 
using a composite approach to mimicry of the ECM, AG73 was combined with collagen as a 
cell substrate for cell culture. Human dermal fibroblasts (HDFs) developed strong actin 
filaments when grown on AG73/collagen substrates but not on AG73 alone or substrates 
with low collagen concentrations (Fig. 2). The full importance of laminin is still emerging; 
for example, direct interaction between laminin and retinal ganglion cells is required for full 
axon emergence and orientation in vivo. The design of artificial matrices incorporating 
laminin constructs is therefore likely to continue for the study of neural development. 
3.4 Fibronectin 
In humans, the FN gene is comprised of 46 exons within an 82 kb gene and is located on 
chromosome 2 (2q34). Due to extensive alternative splicing of FN pre-mRNA, there are 20 
potential isoforms of FN leading to variants with different functions. The occurrence of 
splicing gives rise to insoluble cell associated FN (cFN) and soluble plasma FN (pFN). FN 
usually exists as a dimer of about 500 kDa composed of two subunits linked by a disulphide 
bond near their C-terminus. Isopeptide bonds form between FN dimers in the N-terminal 
domain to form insoluble (cellular) cFN. The association of FN with cell surface integrins is 
the main motivator behind this process. 
The FN monomers consist of three types of repeating unit, termed type I, type II and type 
III. Each repeating unit has a different number of amino acid residues with type I usually 
consisting of about 40, type II comprising of approximately 60 and type III having around 90 
amino acids. Furthermore, type I and II each have two intrachain disulphide bonds while 
type III domains do not contain any disulphides. Typically, FN contains 12 type I repeats, 
each with stacked ǃ-sheets enclosing a hydrophobic core. There are two type II repeats 
comprising disulphide linked perpendicular anti-parallel ǃ-sheets. Type III repeats make up 
approx. 90 % of the FN sequence, with 15 to 17 repeats.  
There are at least 11 heterodimeric integrins which FN can bind to in a cell and tissue 
specific manner, the best characterised of these are integrins ǂ5ǃ1 and ǂvǃ3. FN also contains 
multiple binding sites for other ECM compounds including heparin  and collagen. The short 
polypeptide sequence, RGD, located on the peptide loop in the 10th FN type III domain 
(FIII10) is the key attachment site for integrins. In addition to this sequence, a “synergy site” 
(PHSRN) has been located to the 9th FN type III domain (FIII9), which is required for 
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Fig. 2. Cell spreading on AG73/collagen matrices. A; HDFs (5 × 103 cells) were allowed to 
attach for 1 h and then stained with crystal violet. Photomicrographs of attached cells on 
AG73 (3 pmol/mm2), low amount of collagen matrices (Low collagen: 30 pg/mm2), 
AG73/low amount of collagen matrices (AG73/low collagen: AG73 = 3 pmol/mm2, 
collagen = 30 pg/mm2), and high amount of collagen matrices (High collagen: 150 pg/mm2). 
Scale bar = 50 μm. B; AG73 (3 pmol/mm2), low amount of collagen (Low collagen: 30 
pg/mm2), AG73/low amount of collagen (AG73/low collagen: AG73 = 3 pmol/mm2, 
collagen = 30 pg/mm2) were coated on 8-well glass chambers. HDFs (8 × 103 cells) were 
allowed to attach for 1 h. Cells were fixed, and then stained with phalloidin, anti-vinculin 
antibody, and DAPI for actin filaments (green), focal contacts (red), and nucleus (blue). Scale 
bar = 50 μm. C; Images were captured and the area of the attached cells was measured using 
Bio Zero microscope (Keyence). The attached cells in three randomly selected fields were 
evaluated. Each value represents the mean ± S.D. of triplicate experiments. Triplicate 
experiments gave similar results. *P < 0.001, n.s. = not significant. (Reprinted from 
Biomaterials, vol 32, Y. Yamada, F. Katagiri, K. Hozumi, Y. Kikkawa, M. Nomizu, Cell 
behavior on protein matrices containing laminin ǂ1 peptide AG73, 4327-35, Copyright 2011, 
with permission from Elsevier.) 
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maximum binding to integrin ǂ5ǃ1. Conformational stabilisation of FIII9 occurs through 
interaction with its neighbouring domains, particularly the 8th type III FN domain (FIII8). 
The domain-domain mobility between FIII9 and FIII10 is unusually high; constricting this 
mobility by introducing an interdomain disulphide bridge brings about a change in the 
relative orientation between the RGD- and PHSRN-bearing loops and a decrease in ǂ5ǃ1 
binding avidity (Fig. 3). Thus, while cell adhesion and spreading can be controlled through 
site-directed mutation of key residues in binding motifs, an alternative route would be to 
subtly alter the FIII9/FIII10 scaffold architecture. 
 
 
Fig. 3. Ribbon diagram of a mutant FIII9–10 domain pair constrained through an additional 
disulphide bridging the domain-domain interface. The PHSRN and RGD motifs on FIII9 
and FIII10 are shown as sticks in magenta and blue, respectively. The added disulphide 
bridge is shown as sticks, with sulphurs shown in yellow. Atomic coordinates were 
obtained from the Protein Data Bank (www.pdb.org; ref. 1FNF)  and imaged using PyMol 
(The PyMOL Molecular Graphics System, Version 1.2, Schrödinger, LLC). 
4. Temporal changes to the ECM 
Interaction of cells with artificial ECM matrices in vitro starts at nanoscale level 
(ligand/receptor) and progresses gradually to the organization of cells which can be 
millimetre to centimetre sized. These changes start with the binding of integrin receptor(s) 
to ECM protein(s), which swiftly causes integrin receptor clustering and organisation of 
focal adhesions. From an engineering viewpoint, it is the nanoscale which must be 
recapitulated in the synthetic biomaterial, ideally then permitting further temporal changes 
such as changes in stiffness concomitant with cell adhesion, proliferation and differentiation. 
This work is generally related to directed differentiation of adult stem cells, since it has been 
shown that the mechanical properties of hydrogels promote stem cell self-renewal. For 
example, maturation of cardiomyocytes is associated with a stiffening in the cells’ local 
environment due to changes in collagen deposition. To mimic this change in a biomaterial, 
thiolated-hyaluronic acid (HA) hydrogels were crosslinked with poly(ethylene glycol) 
diacrylate of varying molecular weight, wherein the gel properties changed over time as a 
function of the progression of crosslinking. In this manner the stiffness of the hydrogel 
could be controlled to values eventually approximating cardiac tissue. Stiffening was seen to 
be associated with 60% more maturing muscle fibres, compared to static hydrogels. 
The concept of temporal regulation of cell adhesion in synthetic scaffolds was also 
introduced for human mesenchymal stem cell (hMSC) culture. This built on data showing 
that upregulation the matrix metalloproteinase MMP-13 by hMSCs was coincident with 
www.intechopen.com
Control of Mammalian Cell Behaviour  
Through Mimicry of the Extracellular Matrix Environment 
 
513 
down regulation of FN deposition, as normally required for chondrogenesis. The 
polyethylene glycol (PEG)-peptide matrices developed were interesting because for the first 
time, biomaterials with an inherent ability to down regulate cell adhesion were 
demonstrated. The PEG hydrogels were tethered to peptides harbouring the MMP-13 
cleavage site and RGD motif (full sequence, CPENFFGRGDSG), and then utilised to 
encapsulate hMSCs for culture (Fig. 4). The hMSCs encapsulated in either cleavable or non-
cleavable (control) PEG-RGD hydrogels and cultured in chondrogenic media were seen to 
maintain their viability over 11 days. However, over the following 2 weeks, the hMSCs 
cultured in cleavable PEG-RGD substrates lost their viability by around 66% because MMP-
13 production caused RGD cleavage from the PEG polymeric scaffold. 
 
 
Fig. 4. hMSCs were entrapped in PEG–peptide gels in either control (▲) or chondrogenic (■) 
media. The composition of the gels was either PEG with 10 mM CRGDSG (non-cleavable 
RGD, open symbols) or PEG with 10 mM CPENFFGRGDSG (cleavable RGD tether, closed 
symbols). The cell constructs were analysed for viability as measured via DNA amounts and 
normalized to the initial time point (A). These cell/gel materials were also analysed for 
glycosaminoglycan deposition (B). Finally the cell-surface integrin (ǂ5ǃ1) was stained in the 
cleavable RGD chondrogenic culture on day 3 (C) and day 24 (D) to determine the 
regulation of this adhesion binding complex. Heavy red staining on day 3 is indicative of 
integrin surface markers, where little to no red staining on day 24 indicates that this marker 
has been down regulated by the cell. (Reprinted from Biomaterials, vol. 29, C. N. Salinasa 
and K. S. Anseth, The enhancement of chondrogenic differentiation of human mesenchymal 
stem cells by enzymatically regulated RGD functionalities, 2370-2377, Copyright 2008, with 
permission from Elsevier.) 
Photo-activated cleavage is an attractive approach since it is more efficient and controllable 
than endogenous of exogenous enzyme mediate cleavage. Previously, photo-activated 
cleavage of RGD from 2-dimensional (2-D) cell substrates has also been achieved but only to 
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switch cell adhesion ‘on’ or ‘off’. The development of selectively adhesive plasticware in 
which the use of UV light could control the adhesion of cells was achieved by the use of 
photo-caged RGD based peptide. This has been done in two comparably different manners. 
Firstly, a carboxylic acid side chain, 3-(4,5-Dimethoxy-2nitrophenyl)-2-butyl ester (DMNPB), 
was introduced onto the aspartic acid of RGD. The introduction of this may have affected 
the steric hindrance or conformation of the peptide which reduced binding affinity, shown 
by reduced fibroblast cell attachment. The irradiation of the plate cleaved the DMNPB, this 
was demonstrated by increased DMNPB in solution measured by UV absorbance following 
UV incubation at 364 nm for 2 hours, and increased spreading of fibroblasts plated onto 
surface. Direct blocking of the RGD motif using a 2-nitrobenzyl group has also been 
employed by introduction of nitrobenzyl at the amide bond between the Gly and Arg. The 
placement of the group here essentially switched off the binding capability, which was then 
restored by UV irradiation; this was demonstrated in an exposure dependant manner. A 
non-linear relationship between exposure time and cell adhesion was found, suggesting that 
there may be an upper limit for adhesion. Although not detailed in these studies, there is the 
potential for cell damage from heat produced by the light source. The use of a small 
nitrobenzyl group would preferable in a hope that it would not irreversibly alter the binding 
peptide. The coupling of this with integrin selective binding peptides/proteins would be 
interesting for further studies to control 2-D and 3-dimentional (3-D) tissue matrices. 
5. Generating a polyvalent integrin ligand display 
5.1 Recombinant fibronectin ligands and the ‘RGD’ motif 
Organization of FN fibrils in the extracellular matrix renders a polyvalent display of ligand 
to cell surface integrin receptors. Previous work has shown that integrin-driven 
polymerization of soluble FN is dependent on extension of the FN monomer in order to 
expose self-associating sites. The resultant fibrils are able to undergo extension/contraction 
over a four-fold change in length, yielding an elastic matrix. Such dynamic movements 
within the cell matrix inevitably change both the matrix rigidity and the spatial arrangement 
of the ligand display ‘seen’ by the cell. Interestingly, fibroblasts have been shown to probe 
the elasticity of their supporting matrix, responding to greater elasticity with increased 
motility and protruding lamellipodia but decreased ‘spread’ morphology. A key driver in 
biomaterials research has been the search for suitable mimics to the dynamic nature of the 
ECM, with some solutions described above. A vast amount of work has focussed on the 
RGD motif which is found in multiple ECM proteins and is probably the most recognized 
peptide sequence associated with cell adhesion. It is therefore a predictable target for 
simulated cell adhesion to surfaces.  
However, there have been recent challenges to the extent to which peptides like RGD can 
accurately mimic the local cellular environment, despite ingenious engineering approaches. 
One concern is the ability of peptides to selectively bind the different integrin subtypes, and 
here protein fragments may prove more useful since they have been shown to distinguish 
between integrin ǂ5ǃ1 and ǂ5ǃ1 subtypes. Similarly, the affinity of binding to the several 
integrin receptors which recognize the sequence may be modulated by the conformation of 
the RDG loop and the surrounding amino acids within the protein. There are two 
fibronectin fragments which are commonly reported in the literature. The first is a domain 
pair encompassing the 9th-10th type III FN domains (FIII9-10), wherein a key substitution of 
proline for leucine-1408 in FIII9 is used to increase the conformational stability of this 
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domain by introducing a Pro-Pro pair  (cf. Fig. 3). This mutant, termed FIII9’10, has been 
used to generate polyvalent ECM mimics and support embryonic stem cells, discussed 
below. The second fragment is larger and encompasses the 7th-10th type III FN domains 
(FIII7-10). In vitro, FIII7-10 tethered surfaces promoted rat bone marrow stromal cells 
adhesion via integrin ǂ5ǃ1 while in vivo, FIII7-10 functionalized implants placed in 
artificially created rat tibia cortical defects, exhibited a 70% increase in the bone-implant 
contact area. A third, recent chimeric fibronectin fragment has been reported which brings 
the heparin-binding 1st type III FN domain alongside the 8th type III FN domain, which was 
further engineered to harbour the RGD motif (termed III1H,8RGD). A series of related, larger 
chimeras incorporating 8th, 9th and 10th type III domains were also described. The advantage 
in utilising the heparin binding domain was shown to lie in generating higher rates of cell 
proliferation. 
5.2 Monomeric versus multimeric ligands 
Since FN exists in the ECM as a dimer presenting six cell adhesion domains within a small 
area, when emulating this polyvalent display it would be prudent to strive for a similar 
tactic, suggesting that multimeric, clustered ligands would be preferable. Multimeric ligands 
displaying the RGD motif have been shown to better support cell motility and migration 
compared to monomeric ligands. Furthermore, higher ligand density and cluster size has 
been shown to increased the strength of attachment of fibroblast cells. Although simple non-
clustered RGD ligands were capable of supporting cell attachment, they were unable to 
exhibit full spreading of fibroblast cells. An alternative approach to generating a polyvalent 
RGD display as has been the self-assembly of ǃ-sheet peptides harboring RGD which form 
regular nanofibre structures. Some related amphiphilic peptide assemblies have involved 
elaborate work to include both the RGD and PHSRN peptide motifs, generating fibres 
around 10 nm in diameter and several microns in length. Such self-assembly approaches 
challenge the need to coat non-functional polymeric 3-D scaffolds with bioadhesive 
peptides/proteins, but may be limited with regard to scale-up/cost for clinical application. 
However, as mentioned above, RGD peptides have certain limitations in their ability to 
recapitulate key aspects of the ECM, particularly integrin subtype selection. The challenge is 
to design self-assembling systems for protein fragments, but taking into account their labile 
nature: that is, one cannot simply expose proteins to synthetic chemistry which involves 
organic solvents likely to unfold the protein fragment. Ideally, the self assembly of proteins 
would involve the independent formation of an organized stable structure through non-
covalent forces such as hydrogen bonds, ionic bonds and van der Waals interactions. The 
application of self assembling proteins is diverse and has included the pH induced 
formation of a self assembled artificial protein hydrogels. Application to biomimetic 
materials has been explored by compiling helical coiled-coils for di-, tri- and tetra-helical 
multimers. The stability and order of these coiled coil structures has been encouraging for 
application towards functional biomaterials. 
The construction of a coiled coil system involving FN has been achieved by selective 
mutation of key amino acids in a heptad repeat of the GCN4 leucine zipper helix to allow 
for direct self assembly of parallel coiled coils. A spacer based on an IgG hinge was included 
to prevent steric clashes between bound integrin receptors (i.e. N-FIII9’10-hinge-coiled coil-
C). In this case, the mutant fibronectin fragment FIII9’10 was utilized because of its 
previously reported conformational stability. In this way, the FIII9’10-dimer, -trimer and -
tetramer were constructed, and the effect of these multimeric systems on baby hamster 
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kidney cells and primary endometrial stromal cells was analysed. For both fibroblast and 
stromal cell lines, increased cell attachment and spreading were observed with increasing 
multimerisation of FIII9’10. The morphology of the spread stromal cells on the FIII9’10-
tetramer recapitulated their spread morphology on FN (Fig. 5), and suggests that multimeric 
constructs will have a role to play in endometrial tissue engineering. Translation of these cell 
data from 2-D ligand displays to 3-D scaffolds under perfusion culture is currently 
underway. 
 
 
Fig. 5. Morphology of EnSCs on surfaces derivatised with multimeric and monomeric 
integrin ǂ5ǃ1 ligands. Cells were plated onto neutravidin surfaces incubated with 0.5 µM 
ligand coating concentration of FIII9'10-GGC (A), FIII9’10 (B), dimer (C), trimer (D), tetramer 
(E) and FN (F), and stained for vinculin (green), actin (red), and nuclei (blue). Bar, 16 µm. 
(Reprinted from Biochem. Biophys. Res. Commun., vol. 407, Z. Li, M. Kreiner, C. F. van der 
Walle, H. J. Mardon, Clustered integrin ǂ5ǃ1 ligand displays model fibronectin-mediated 
adhesion of human endometrial stromal cells, 777-82, Copyright 2008, with permission from 
Elsevier.). 
6. Non specific versus directed protein adsorption 
Non-specific adsorption of a protein to a surface usually involves the incubation of the 
desired surface in a protein solution. The protein adsorbs to the surface through non specific 
interactions such as hydrophobic and electrostatic forces. Directed protein adsorption 
through covalent surface modification involves the attachment of mechanisms to the ligand 
display. These can be in the form of, polymer side chains, self assembling monolayers or 
components of a lipid bilayer. The generation of model substrates which present defined 
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binding motifs, such as RGD, from the ECM are subjected to many issues. The importance of 
ligand conformation may be compromised by the immobilized proteins undergoing 
denaturation or adsorption in the ‘incorrect’ orientation (i.e. resulting in the ligand not being 
available for receptor binding). In order to have well defined substrates with reproducible 
results these changes during adsorption should be characterized and/or controlled. 
The non-specific adsorption of a protein from bulk solution to a solid/liquid interface 
may incur: i) a change in its conformation , ii) relaxation and partial desorption , iii) 
reorientation and alignment as a function of surface coverage. The protein layer may also 
undergo transition from a monolayer to a multilayer as the surface becomes saturated. 
Changes in orientation and surface coverage were seen for random adsorption of FN 
fragments, wherein the adsorption model was analogous to the surface pressure area 
isotherm of surfactants. Concomitant structural changes were also observed during the 
random adsorption of FIII9’10 to silica, wherein a distorted, non-native conformation was 
observed to be associated with the aromatic residues being held in a more ridged state. 
However, in order to better define the relationship between cell behavior and a 2-D ligand 
display, it is necessary to characterise the ligand pattern and density that is interrogated 
by the cell surface integrin receptors. This requires an engineering approach in which 
ligands are tethered in a controlled manner to the surface. Such approaches have been 
described for RGD-peptides at least, with the development of comb-like polymers and 
self-assembling monolayers (SAMs) permitting the calculation of ligand densities and 
ligand clustering. 
Application of SAMs to larger protein domains remains unclear since the cross-linking of 
proteins to the gold/alkanethiolate brush border appears to leave significant proportions of 
the immobilised protein non-specifically adsorbed. Similarly, one report for cross-linking 
FIII7-10 to adsorbed BSA did not address random ligand orientation or adsorption-induced 
unfolding. A carrier or tether facilitating uniform ligand orientation upon immobilisation is 
therefore required. Such tethers have been described for FN fragments, using either a 
unique C-terminal cysteine residue which can be specifically biotinlylated for controlled 
binding to a streptavidin surface (Fig. 6), or covalent conjugation through a synthetic 
protocol. With respect to the latter, clinical-grade titanium implants grafted with a non-
fouling polymer coating, functionalised with a controlled density (0.9 pmol/cm2) of FIII7-10 
have been tested in vitro and in vivo  (Fig. 7). It is also possible to translate the specific ligand 
orientation that can be achieved in 2-D through the use of tether to 3-D scaffolds, so long as 
the appropriate chemistry is based on aqueous solvents which maintain protein integrity. 
7. Stem cell behavior and substrate ‘stiffness’ 
An important outcome of the studies on ECM-directed control of cell behaviour will be 
improvements in our ability to grow mammalian embryonic stem (ES) cells in culture 
systems completely free of animal material. Given the therapeutic potential for cultured 
cells, development of such animal free systems is a major imperative. This is most pressing 
in the field of stem cell biology where human ES (hES) cells provide a potentially novel 
source for the derivation of transplantable tissue specific cell types. ES cells were initially 
developed from the inner cell mass of the d3.5 murine blastocyst  and have been 
demonstrated to be capable of contributing to all three germ layers of the developing 
embryo. These murine ES (mES) cells can differentiate in vitro to give rise to a wide range of 
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Fig. 6. Cartoons of the biotinylated monomeric (FIII9'10-GGC) and multimeric integrin ǂ5ǃ1 
ligands orientated to the neutravidin coated 2D substrates. (Reprinted from Biochem. 
Biophys. Res. Commun., vol. 407, Z. Li, M. Kreiner, C. F. van der Walle, H. J. Mardon, 
Clustered integrin ǂ5ǃ1 ligand displays model fibronectin-mediated adhesion of human 
endometrial stromal cells, 777-82, Copyright 2008, with permission from Elsevier.). 
 
 
Fig. 7. Poly(OEGMA) brushes with ligand tethered on titanium. (A) Schematic of FNIII7–10-
tethered poly(OEGMA) brush system on titanium. Both linear RGD peptide and a 
fibronectin fragment FNIII7–10 (purple) containing both the RGD (red) and PHSRN (yellow) 
sequence in the native ECM structural conformation were tethered to poly(OEGMA) 
brushes via NPC chemistry. Unactivated hydroxyl groups provided the non-fouling nature 
of the brushes. (B) Tethering scheme of integrin ligands to “activated” poly(OEGMA) 
brushes on titanium. (Reprinted from Biomaterials, vol. 29, T. A. Petrie, J. E. Raynor, C. D. 
Reyes, K. L. Burns, D. M. Collard, A. J. García, The effect of integrin-specific bioactive 
coatings on tissue healing and implant osseointegration, 2849-57, Copyright 2008, with 
permission from Elsevier.). 
mature cell types such as haemopoietic cells, cardiac muscle cells, endothelial cells and 
neurons. Isolated hES cells have also been shown to contribute to all three germ layers. The 
ability of these cells to differentiate in vitro to give rise to a range of tissue cell types has 
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prompted much research into the use of these hES cells as sources of transplantable cells. 
Whilst this currently looks like a promising option, clinical use of these cells will require 
extremely well defined culture systems and thus any advances in our understanding of the 
use of synthetic replacements for animal products in the regulation of self-renewal and 
differentiation of ES cells will be important. 
The nature of the ECM is also known to regulate ES cell behavior. For example, mES cells 
cultured on type I and type IV collagen or poly-D-lysine retained an undifferentiated state 
but when cultured on laminin or FN displayed altered morphology and downregulated 
signal transducer and activator of transcription 3, which maintains ES cell self-renewal. 
Inhibition of integrin-fibronectin binding prevented the observed differentiation response 
and in serum-replacement media the mES cells expressed integrin subtypes specific for 
laminin and fibronectin, but not for collagen. It is therefore apparent that the integrin 
subtype specific for fibronectin, namely integrin ǂ5ǃ1, is likely to play a role in mES cell 
behavior upon adhesion to ECM. As for stromal and fibroblast cells (discussed above), mES 
cells showed clear morphological responses to clustered versus monomeric FN fragments. 
The mES colonies appeared disperse with a spread cell morphology on dimeric FIII9’10, 
unless subdued back to a tight morphology with increasing concentrations of leukaemia 
inhibitory factor (LIF) (Fig. 8). In the presence of LIF, mES cells adherent to the FIII9'10-
dimer also showed transient upregulation of Oct-4, the mesodermal transcription factor, 
Brachyury, and the ectodermal marker, Nestin. However, dual upregulation of Nanog 
maintained the mES cells in a pluripotent state, confirmed by alkaline phosphatase staining. 
Since the mES cells grow as dispersed colonies in a monolayer, FIII9'10-dimer could have 
application as an alternative substrate on which to study ES cell differentiation in 2-D. 
 
 
Fig. 8. mES cells stained with Giemsa after culture in complete media for 3 days and 
adherent to 0.1% gelatin (A), or 100 μg/ml FIII9'10-dimer on which there appear ‘tight’ (B) 
and ‘dispersed’ (C) mES cell colonies; magnification ×20. (Reprinted from Biochem. Biophys. 
Res. Commun., vol. 390, M. D. Singh, M. Kreiner, C. S. McKimmie, S. Holt, C. F. van der 
Walle, G. J. Graham, Dimeric integrin ǂ5ǃ1 ligands confer morphological and differentiation 
responses to murine embryonic stem cells, 716–721, Copyright 2009, with permission from 
Elsevier.) 
However, cellular responses to ECM signals are context-dependent: ECM signals presented 
in 3-D differ from those presented in 2-D. For example, focal adhesion formation during cell-
ECM adhesion is mechanistically different in naturally derived hydrogels when compared 
to protein-coated tissue culture polystyrene substrates. These context dependent changes are 
due to cell-substrate mechanics, involving local forces generated by the cell during 
spreading  and primary (tissue) cell sensing of the synthetic substrate stiffness, or local 
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variations of ECM elasticity in vivo. Termed ‘mechanotransduction’, this field of study is of 
clear relevance to the design and interpretation of tissue culture on 3D matrices. Mechanical 
cues can also direct adult stem cell commitment. Human mesenchymal stem cells can be 
induced to differentiate into multiple tissue lineages by simple altering substrate 
compliance: softer substrates (0.1-1 kPa) induce neurogenic differentiation, stiffer substrates 
(8-17 kPa) promote muscle formation, while the stiffest substrates (25-40 kPa) produce bone 
cells. In contrast, undifferentiated D1 stem cells (a mouse clonally derived bone marrow 
stromal cell line) show little sensitivity to hydrogel elasticity (20-110 kPa), whereas once 
they are differentiated towards the osteoblast lineage, they became more responsive. 
Mechanical control of phenotype is thus likely to be important for different adult stem cells 
at various stages of differentiation. 
This will involve developing hydrogels containing a bioinert polymer that is furnished with 
spatially defined ECM-derived ligands, while avoiding non-specific interactions with other 
molecules. A defined synthetic biomaterial is preferred over ‘naturally based’ hydrogels 
such as Matrigel and collagens which are biochemically complex (to tune), variable and ill-
defined, and therefore make interpretation of cellular responses more complex. Hydrogels 
are particularly promising because they do not only have a high water content to promote 
cell viability, but they are structurally and mechanically similar to the native ECM of many 
tissues. The polymers forming the hydrogel structure must be bioinert, rather than having 
inherent cell adhesive activity such as gels of fibrin or hyaluronan, in order to test the 
capacity of the gels to support a specific cell function. Bioinert polymers such as alginate or 
poly(ethylene glycol) must therefore be covalently cross-linked with ECM-derived ligands 
to physically resist cell traction forces and prevent ligand leaching. 
The role of integrins in determining self-renewal versus differentiation has been 
investigated using mES cells embedded in hydrogels functionalised with three peptides 
selective for integrins ǂ5ǃ1, ǂvǃ5, ǂ6ǃ1 and ǂ9ǃ1. Broadly, maintenance of mES cell self-
renewal and pluripotency, with down-regulation of differentiation-related genes, required 
multiple integrin subtype binding. It has also been shown that hES cells adherent to 
Matrigel predominantly expressed integrin ǂ6, ǂvǃ3, ǂ2ǃ1 and (particularly) ǃ1. These 
synthetic gels were functionalised with three peptides engaging integrins ǂvǃ3, ǂ5ǃ1 and 
ǂ6ǃ1. As for mES cells, maintenance of self-renewal required multiple integrin engagement, 
with hydrogels functionalised with one peptide supporting only hES cell adhesion and 
pluripotency. Integrin-mediated adhesion has also been shown to regulate the assembly of 
single-cell suspensions of hES cells into pluripotent hES cell colonies in the absence of feeder 
cells or added cytokines.  
A degree of control over cellular processes is desired for regenerative medicine and to this 
end, FN fragments (FIII9’10) designed to specifically target integrin ǂ5ǃ1 were investigated 
in the context of osteogenic differentiation. When FIII9’10 was coated onto surfaces, human 
mesenchymal stem cells displayed increased adhesion, proliferation and spreading 
compared to the (conformationally less stable) wild type FIII9-10. Interestingly, selective 
inhibition of ǂ5ǃ1 was shown to reduce proliferation of cells on FIII9’10 and FIII9-10 but not 
on FN or FIII10, suggesting a degree of specificity. Furthermore, stronger osteoinduction 
potential was exhibited by the FN fragments containing FIII9 compared with full length FN 
and domain FIII10. The lower osteoinductive effects shown on FIII10 would be expected 
because it does not include the PHSRN synergy site which is required for full ǂ5ǃ1 integrin 
binding. FIII9’10 appears to better mimic full length FN with the addition of improved 
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osteoinductive effects mediated through the ǂ5ǃ1 integrin, and this may prove useful for the 
further development controlled cell systems. 
8. Conclusion 
It is highly desirable to control ES cell proliferation and differentiation on 2-D and 3-D 
substrates in order to generate clinically useful tissues for regenerative medicine. To achieve 
this it will be necessary to recapitulate the ES cell niche in vivo, taking into account dynamic 
changes to this environment. Bone formation for example is a complex process which 
encompasses the recruitment and proliferation of osteoprogenitor cells, differentiation, 
matrix formation and mineralization. It is clear then that the field of ECM engineering for 
the control of cell behaviour must align with complementary fields, namely soluble 
cytokines and growth hormones that are required constituents of cell media and also direct 
cell behaviour. However, it should not be overlooked that scale-up of cell culture for 
medical applications presents another challenge, wherein cell substrates must be conducive 
to fermentor/cell expansion technologies. While the biomaterials field has focussed on 
assembling peptide motifs which mimic the central cell binding domains of ECM proteins, 
particularly RGD, there appears to be a current move towards the use of protein fragments 
which can incorporate multi-functional roles. It is unlikely that any one ECM mimic will 
gain predominance, not only because each cell type expresses specific integrin subtypes, but 
also because of the various potential uses, from regenerative medicine to bioprocessing. 
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